Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial

Raja Atreya, Laurent Peyrin‐Biroulet, A. V. Klymenko, Monica Augustyn, И. Г. Бакулин, Dusan Slankamenac, Pál Miheller, Antonio Gasbarrini, Xavier Hébuterne, Karin Arnesson, Thomas Knittel, Jan Kowalski, Markus F. Neurath, William J. Sandborn, Walter Reinisch